It is still unclear as to whether the gene expression pro®le in HCV-or HBV-related HCC exhibits a degree of speci®city and whether the development of HCC in a context of cirrhosis in¯uences this gene pro®le. To address these issues, the expression pro®les of 15 cases of HCC were analysed using cDNA macroarray. A global analysis and hierarchical clustering, demonstrated the heterogeneity of HCC patterns, with a majority of down-regulated genes. Statistical analysis clearly showed a distinction between the gene expression pro®les of HCV-and HBV-related HCC. HBV-associated HCC exhibited involvement of dierent cellular pathways, those controlling apoptosis, p53 signalling and G1/S transition. In HCV-related HCC we identi®ed a more heterogenous pattern with an over-expression of the TGF-beta induced gene. In HCC developing on noncirrhotic tissues, beta-catenin encoding gene and genes implicated in the PKC pathway were speci®cally upregulated. In addition, our investigation highlighted a distinct pro®les of TGF-beta superfamily encoding genes in well, moderately or poorly dierentiated HCC. Overall, our study supports the hypothesis that despite the heterogeneity of the HCC pattern, the large-scale screening of gene expression may provide data signi®cant to our understanding of the mechanism of liver carcinogenesis.
Introduction
Hepatocellular carcinoma (HCC) is one of the most common malignant tumours worldwide. Most cases of human HCC (around 90%) develop in a setting of chronic in¯ammation, with chronic active hepatitis or cirrhosis, however, a subset of HCC occurs in the absence of cirrhosis. Numerous aetiological factors have been identi®ed, including chronic Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) infections, alcoholism, chemical carcinogens (A¯atoxin B1), or iron overload (Stuver, 1998) .
A number of genetic and epigenetic alterations have now been reported in HCC (Buendia, 2000; Feo et al., 2000; Laurent-Puig et al., 2001) . High density allelotyping and comparative genomic hybridizations have enabled the de®nition of an emerging pattern of genetic alterations. HCC appears clearly as a tumour characterized by considerable loss of heterozygosity (LOH) and a low level of microsatellite instability. LOH from chromosomes 1p, 4q, 6q, 8p, 9p, 13q, 16p, 16q, and 17p has been identi®ed as the most frequent. Point mutations have been reported in genes encoding p53, beta-catenin and Axin. However, these mutations are only detected in around 20 ± 30% (p53, betacatenin) or 5 ± 10% (Axin) of HCCs. RB-1, ECadherin, IGF II Receptor and Smad 2 and 4 genes are less frequently altered. The deregulation of cell cycle controlling genes such as cyclin D1, cyclin A and p16 has also been reported, decreased p16 expression being associated with hyper-methylation of the regulating sequences. Other genes implicated in liver regeneration, such as TGF-a, HGF, TNF-a and IL6 encoding genes may also be implicated in the development of HCC (Fausto, 1991) .
It has clearly been established that HBV and HCV infections are major risk factors for the development of HCC (Kasai et al., 1996) . A number of genetic alterations have been described in several HCC related to HCV or HBV (Buendia, 2000; Kusano et al., 1999; Tornillo et al., 2000) . Various carcinogenetic mechanisms have been described in HBV-related HCC (Brechot et al., 2000) . The integration of HBV DNA can directly induce chromosomal instability and insertional mutagenesis. Chromosomal DNA instability is indeed an important consequence of HBV DNA integration leading to LOH or translocations. The cisactivation of cellular genes, described to date as a rare event in human HCC, may in fact be more prevalent, this having been revealed thanks to major advances in the human genome sequencing project and the larger number of HCC cases analysed (Gozuacik et al., 2001) . Viral proteins, such as HBx or PreS2/St, are also probably implicated in liver cell carcinogenesis. There is evidence that HBx modulates cell growth and viability, many of its biological eects being associated with its trans-activation and protein-protein interaction abilities (Murakami, 1999) . The HCV genome, a member of the Flaviviridae, does not integrate the cellular genome (Shimotohno, 2000) . Some viral proteins, such as the core, NS3 and NS5A proteins, have been reported to aect cell proliferation, viability and response to interferon signalling Hayashi et al., 1999; Podevin et al., 2001 ). In particular, there is some evidence that HCV core protein, a transcriptional regulator of several cellular genes, may induce liver cell transformation under certain experimental conditions (Ray and Ray, 2001) .
Despite all these ®ndings, no unifying mechanisms have been proposed which could account for liver carcinogenesis. There is evidence for an association between certain chromosomal alterations and the HBV or HCV status of HCC, but the molecular basis of these observations remains unclear (Buendia, 2000; Tornillo et al., 2000) . Furthermore, apart from the determination of alpha-fetoprotein serum levels, currently used for the diagnosis of HCC, we still lack reliable markers for early tumour detection (Pateron et al., 1994) . Finally, although some prognostic markers have been reported in certain cases of HCC there is clearly a need for identifying more reliable markers.
cDNA microarray is a powerful technology which enables the large-scale screening of gene expression. It has already been used to analyse several human cancers. cDNA microarray with or without hierarchical clustering allows the correlation of gene expression pro®le with clinical factors, the classi®cation or de®nition of dierent tumour types, and the identi®ca-tion of genes or networks of genes involved in carcinogenesis (Alizadeh et al., 2000; Bertucci et al., 2000; Clark et al., 2000; Golub et al., 1999; Perou et al., 2000; Welsh et al., 2001) .
Some recent studies based on cDNA microarray technology have been performed in HCC. Certain studies investigated HCC without associated viral infection, or, in contrast, with HBV-or HCV-related HCC (Lau et al., 2000; Shirota et al., 2001; Xu et al., 2001) ; however only one study has so far compared HBV with HCV-related HCC (Okabe et al., 2001 ). Thus it is still unclear whether the gene expression pro®le in HCV-or HBV-related HCCs exhibits a degree of speci®city, and whether the development of HCC in a setting of cirrhosis in¯uences this gene pro®le. To address these issues, we have analysed a series of HCC cases associated with HCV-or HBVinfections and developing on cirrhotic or non-cirrhotic tissues. In addition, so as to identify the genes related to the progression of carcinogenesis, we also compared the gene expression pro®les of well, moderately or poorly dierentiated HCCs.
Results

cDNA macroarray hybridizations and RT ± PCR validations
So as to avoid individual genetic variations, we compared the gene expression pro®les of tumour (T) and non-tumour (NT) tissues obtained from the same patient (Table 1) . To evaluate the reproducibility of cDNA macroarray data, we performed two independent experiments for each patient. When the duplicate experiments were compared, a percentage of reproducibility ranging from 67 to 90% was observed. Our results indicated a global reproducibility of results, with some discrepancies in the genes expressed. We therefore decided to perform the dierent analyses taking account of all the experiments.
Semi-quantitative RT ± PCR was performed to verify macroarray hybridization data. Four paired T and NT tissues from patients with HCC were used, and the level of RNA expression in seven selected genes were evaluated in paired tissue samples (Figure 1 ). Ampli®ed fragments from T and NT tissues were compared after being normalized by the intensity of the 40S ribosomal encoding gene, used as an internal control. In most cases (22/24, 92%), the signal intensity ratio obtained from macroarray data correlated well with semiquantitative RT ± PCR data.
Hierarchical clustering
Hierarchical clustering was performed, organising the 30 experiments and selected genes (105) on the basis of similarities in their gene patterns (Figure 2 ). Thirteen of the 15 patients analysed in duplicate clustered together on the terminal branches of the dendogram, indicating that their gene expression pro®les were comparable. The resulting dendogram showed four cluster branches (I ± IV) ( Figure 2b ). The distances between branches I and II and between branches III and IV re¯ected the relatedness of the samples. A majority of HBV-related HCCs were linked to branches I and II, and a majority of HCV-related HCCs to branches III and IV. These results suggested an association between HCC gene expression pro®les and HBV/HCV status. In addition, branch III only included patients who had developed HCC on cirrhotic tissue and not on non-cirrhotic tissue, independent of their viral status. Hierarchical clustering showed multidimensional variations in gene expression pro®les, illustrating the heterogeneity of the dierent HCC patterns (Figure 2a ). Despite this heterogeneity, most genes were found to be downregulated in HCC, and two distinct clusters of downregulated genes were observed in the gene dendogram. In the ®rst cluster (Figure 2c ), the majority of genes belonged to the immune system family. This probably re¯ected the in¯ammatory cellular in®ltrate present in non-tumourous tissue. In addition to these genes, two others were found to be down-regulated. Alpha-2-macroglobulin, a plasma glycoprotein known to act as an irreversible inhibitor of a variety of proteinases, binds numerous growth factors, cytokines and hormones, such as TGF-beta (Feige et al., 1996) . The interferon-inducible protein 9-27 (Leu-13) is associated with CD19/CD21/CD81/TAPA-1 on the surface of B cells, generating signal transduction activations and controlling cell growth (Bradbury et al., 1992) . The second cluster included nine genes that were downregulated, mostly in patients clustering on branches I and II of the dendogram ( Figure 2e ). Among these genes (aminoacylase 1, STAT-induced STAT inhibitor 3, haemoglobin, metallothionein-III), some have already been described as being modulated in HCC or cancer-derived cell lines (Garrett et al., 1999; Miller et al., 1989; Okabe et al., 2001) . In addition to these clusters of down-regulated genes, a cluster with a majority of up-regulated genes was observed ( Figure  2d ). Two of the four up-regulated genes corresponded to those implicated in DNA repair and in the ubiquitin/proteasome pathway (Ubiquitin-conjugating enzyme E2, UV excision repair protein-Rad23), deregulation of which may contribute to carcinogenesis (Schauber et al., 1998; Weissman, 2001) . We then performed a second hierarchical clustering, based on gene analysis alone and not on both genes and patients, to test for the possible association of gene expression pro®les and virological or pathological features of HCC ( Figure 3 ). The hierarchical clustering of genes with patients arranged according to their HBV/HCV status, highlighted a group of nine clustered genes dierentially expressed in HCV-or HBV-related HCC (Figure 3a ). This gene cluster was identical to one of those described above in the global cluster analysis (Figure 2e ). This was consistent with an association between the down-regulation of these genes and HBV infection. Hierarchical clustering of genes based on the dierentiation status of HCC highlighted a cluster of three genes which were preferentially downregulated in moderately/poorly dierentiated HCC and up-regulated in well dierentiated HCC (Figure 3b) . One of these genes was aldehyde oxidase, which is involved in NAD oxidation (Mira et al., 1995) . The down regulation of plasminogen had been found previously in a global HCC analysis, but no data was available concerning a possible association with the histological dierentiation of HCC status (Okabe et al., 2001; Shirota et al., 2001) . No clear dierence in gene expression in the cluster could be seen between HCC developing in the context of cirrhosis or not (data not shown). However, interpretation of this hierarchical clustering analysis was hampered by the small number of HCC cases developing on non-cirrhotic tissues.
Identification of genes differentially expressed in HCCs
Because hierarchical clustering highlighted multidimensional variations in HCC gene patterns, we examined genes that were up-or down-regulated in more than 30% of the 30 comparisons so as to better de®ne genes which are dierentially expressed in HCC. Of the 1098 genes modulated in HCC, 14 or the 553 up-regulated genes and 30 of the 545 down-regulated genes were found to be modulated in at least 30% of the comparisons (Table 2) . Among those genes, 10 were found to be down-regulated in at least 50% of the comparisons. As previously illustrated by the hierarchical clustering, a large number of genes were down- Figure 3 Hierarchical clustering of genes. Patients were arranged in terms of their viral aetiology and histological features. Red and green colour illustrate over-expressed and under-expressed genes in tumoral tissues, respectively; black and grey represent unchanged or absent of gene expression in tumoral and non-tumoral tissues. The dendrogram and coloured images were produced as described by Eisen et al. (1998) ; the colour scale ranged from saturated green for log ratios 73.417 to saturated red for log ratios 3.417. (a) Group of nine clustered genes dierentially expressed in HCV-or HBV-related HCC (HBV/HCV). (b) Group of three genes preferentially down-regulated in moderately/poorly dierentiated (PmD) HCC and up-regulated in well dierentiated (WD) HCC regulated when compared with over-expressed genes. Several of these genes may be integrated in the networks of genes acting at dierent levels of cell signalling.
A ®rst group of genes involved in the immune response (immunoglobulins, lymphocyte antigen) was found to be down-regulated, as illustrated by the hierarchical clustering (Figure 2c ). A second group of genes, regulating the composition of the extra-cellular matrix and the cytoskeleton (Fibronectin, Tubulin alpha1, matrix metalloproteinase 14, osteonectin SPARC, RhoA) was found to be up-regulated. These genes have been described as being up-regulated in variety of carcinomas and in HCC (Kamai et al., 2001; Polette and Birembaut, 1998; Porte et al., 1998; Takano et al., 2001; Takayasu et al., 2001) . Taken together, these results support the hypothesis that the deregulation of genes encoding proteins associated with the cytoskeleton plays a role in liver carcinogenesis (Le Bail et al., 1997) . It should be noted that, osteonectin, an extra-cellular matrix-associated glycoprotein, regulates the activation of matrix metalloproteinase 2, collagen type I and TGF-beta 1, and has been reported to be involved in oesophageal and breast cancers (Francki et al., 1999; Gilles et al., 1998; Porte et al., 1998) . Like beta-catenin, osteonectin is involved in regulating many of the extra-cellular matrix proteins implicated in the development of cancer. A third group of genes, related to cell growth and the regulation of dierentiation, was found to be down-regulated in HCC. The expression of NGF-inducible anti-proliferative protein PC3 (BTG2) and insulin-like growth factor (Rouault et al., 1996; Shen et al., 1999) . This observation may re¯ect a down-regulation of the p53 pathway; interestingly, we also observed the down-regulation of early growth response protein 1, implicated in p53 trans-activation (Liu et al., 1998) . A fourth group of genes involved in protein tracking was found to be over-expressed, including ADP/ATP carrier protein and TRAM encoding genes (Hegde et al., 1998) . It should be noted that an alteration to ADP/ATP carrier protein expression, inducing carrier dysfunction, has been described during some viral infections (Schulze and Schultheiss, 1995) . Finally, a ®fth group of genes controlling dierent metabolic pathways was found to be under-expressed, including methylene-tetrahydrofolate dehydrogenase and the metalloenzymes (metallothionein III, betaine-homocystein S-methyltransferase, metalloproteinase inhibitor 1) (Hidalgo and Carrasco, 1998; Hol et al., 1998; Iredale et al., 1992; Millian and Garrow, 1998) .
Association of gene expression patterns with virological and pathological features of HCC
We attempted to establish links between gene expression and viral status (HBV/HCV) (Table 3) , the development of HCC in a context of cirrhosis (Table  4) , and the dierentiation status of HCC (Table 5) . Among the 90 and 43 genes whose expression was modulated in HBV-and HCV-related HCC, respectively, 37 exhibited speci®cally modulated expression pattern in HBV-related HCC, as opposed to only one in the HCV-related HCC (Table 3) . This was consistent with the more heterogeneous gene expression pro®le seen in HCV, rather than HBV-related HCC, as illustrated by the gene hierarchical clustering ( Figure  3a) . However, transforming growth factor beta-induced encoding gene was found to be up-regulated in 44% of HCV-related HCCs. An over-expression of TGF-beta has been reported in HCC, including HCV-related HCC (Abou-Shady et al., 1999; Kim et al., 2000; Thorgeirsson et al., 1998) . Our result suggested the modulation of the TGF-beta pathway in HCV-related HCC. In HBV-related HCC, six of the 25 up-regulated and 31 of the 65 down-regulated genes were found to be speci®cally modulated. In particular, they included genes implicated in the control of G1/S transition (cyclin-dependent kinase regulatory subunit, cyclindependent kinase inhibitor 17(p21)), DNA damage and apoptosis (PIG7, growth arrest and DNA-damageinducible protein (GADD45)) and growth factor synthesis (hepatocyte growth factor activator, growth factor receptor-bound protein 2 (GRB2)) (Demetrick et al., 1996; Dotto, 2000; Lowenstein et al., 1992; Okajima et al., 1997; Polyak et al., 1997; Zhan et al., 1994) .
In HCC developing on non-cirrhotic tissue, 12 of the 32 up-regulated and ®ve of the 31 down-regulated genes were speci®cally modulated (Table 4) . Only four of the 30 down-regulated genes, and none of the 12 upregulated genes were found to be speci®cally modulated in HCC developing on cirrhotic tissue (Table 4) . This was consistent with the more heterogeneous pattern of gene expression in HCC developing in a context of cirrhosis, compared with the pattern seen in non-cirrhotic tissue. This may re¯ect the fact that numerous factors are involved in the development of cirrhosis and thereafter of HCC. In non-cirrhotic tissues, we also noted an over-expression of alpha1-and beta-catenin and type II cytoskeletal 8 keratin encoding genes, which has been reported in dierent types of cancers, including HCC (Endo et al., 2000; Xu et al., 2001) . In addition, the down-regulation of a PKC pathway inhibitor (protein kinase C inhibitor 1) and the up-regulation of a PKC-regulated gene (Llactate dehydrogenase M subunit) suggested activation of the PKC pathway (Juengel et al., 1998; Jungmann et al., 1998) .
In well dierentiated HCC, four of the 33 upregulated and two of the 34 down-regulated genes were speci®cally modulated (Table 5) . One of the 16 upregulated genes and seven of the 35 down-regulated genes were found to be speci®cally modulated in moderately/poorly dierentiated HCC (Table 5) . Among these genes, macrophage inhibitory cytokine 1, a member of the TGF-beta superfamily, was found to be speci®cally down-regulated in 60% and upregulated in 40% of cases of well and moderately/ poorly dierentiated HCC, respectively (Fairlie et al., 1999) . In addition, transforming growth factor betainduced encoding gene was found to be up-regulated in more than 50% of well-dierentiated HCCs. This may re¯ect a dierential regulation of the TGF-beta superfamily encoding genes at dierent stages of liver carcinogenesis. The expression of hepatoma-derived growth factor (HDGF), a regulator of liver cell growth, was found to be up-regulated in more than 50% of well dierentiated HCC and may also contribute to liver cancer progression (Nakamura et al., 1989) . Another network of genes, implicated in several metabolic pathways, was found to be altered in moderately or poorly dierentiated HCCs. In particular, cytosolic superoxide dismutase 1 (SOD1) expression was found to be down-regulated. It should be noted that, SOD2 was reported to be modulated during another study of HCC patterns (Yamashita et al., 2001) . Finally, plasminogen and haemoglobin encoding genes have also exhibited a dierential expression in moderately/poorly dierentiated HCC, as previously reported in two studies of HCC using cDNA microarray technology (Okabe et al., 2001; Shirota et al., 2001) .
Discussion
The most important ®nding of this study is that despite considerable heterogeneity in gene expression pro®les in HCC, a link could be seen between certain gene expression patterns and pathological or virological features of HCC. The heterogeneity of our macroarray pattern did not result from individual genetic variations, since we compared tumour and non-tumour Hierarchical clustering and cDNA macroarray-based analyses allowed us to identify a number of potential gene networks which were deregulated in the context of liver carcinogenesis. Some of these genes, such as betacatenin, p53, TGF-beta and genes involved in G1/S transition, have previously been incriminated in HCC or the development of other cancers (Abou-Shady et al., 1999; Buendia, 2000; Ito et al., 1999; Sato et al., 1999; Vousden, 2000; Wong et al., 2001; Yuspa et al., 1994) . In addition, our analysis has highlighted other regulatory pathways which may be of importance to our understanding of liver carcinogenesis. In particular, we noted deregulation of expression of certain gene encoding carrier proteins, as well as proteins implicated in insulin (SOCS2, IGFBP2, IGFBP3, GRB2, insulininduced protein) and thyroid-dependent signal pathways (HMG I, ADP/ATP carrier, nuclear hormone receptor). Insulin and thyroid hormones have clearly been shown to act as important regulators of liver cell proliferation and dierentiation (Veneziani et al., 1990) . Similarly, the expression of several genes controlling dierent metabolic pathways, such as aldehyde oxidase, metallothionein-III, superoxide dismutase 1, was modi®ed.
HBV and HCV both induce in¯ammation and cirrhosis, but the mechanisms causing carcinogenesis remain unclear. Several reports have suggested an association between some chromosomal alterations and Genes modulated in more than 50% of the comparisons. HBV-and HCV-related HCC. Dierent studies have led to report that a number of genetic alteration are common to HCV-and HBV-related HCCs (Buendia, 2000; Honda et al., 2001; Kusano et al., 1999; LaurentPuig et al., 2001; Tornillo et al., 2000) . Our study adds further support to the hypothesis that liver carcinogenesis induced by HBV and HCV may, in addition to common genetic and epigenetic alterations, involve distinct pathways. Consistent with these results, other reports, focusing on patients with chronic hepatitis with or without HCC, have also suggested a distinct pattern of gene expression association with HBV and HCV infections Genes modulated in more than 50% of the comparisons.
c Genes previously reported in the literature Genes modulated in more than 50% of the comparisons.
c Genes previously reported in the literature Laurent-Puig et al., 2001; Okabe et al., 2001) . Strikingly, HCV-associated HCC exhibits a more heterogeneous gene expression pro®le when compared with HBV-related HCC. The present study has in particular highlighted the link between cell cyclecontrolling gene expression deregulation and HBV infection. The expression of some of these genes (GADD45, PIG7) has been reported to be p53-dependent (Polyak et al., 1997; Zhan et al., 1994) . Their down-regulation implies a modulation of the p53 pathway in HBV-related HCC, as already suggested (Laurent-Puig et al., 2001; Teramoto et al., 1994) . However, we did not detect any alteration to p53 encoding gene expression, so that our observations may therefore re¯ect post transcriptional and/or translational regulations, associated or not with p53 gene mutations, undetectable using our cDNA-macroarray technique. A further potentially important result of our study is the over-expression of TGF-beta induced-encoding gene in HCV-related HCC. To our knowledge, a speci®c alteration to the TGF-beta pathway in HCV-related HCC has only been reported in one study, to date (Kim et al., 2000) .
Our ®ndings also provide further support for the hypothesis of dierent pathways being involved in liver carcinogenesis, associated or not with cirrhosis. A few genetic alterations have been reported speci®cally in HCC developing in a context of non-cirrhotic HCC, such as 13q and 8p LOH (Laurent-Puig et al., 2001; Terris et al., 1999) . The results of the present study are consistent with the involvement of the PKC dependent pathway in such tumours. We also observed an upregulation of the beta-catenin-encoding gene. Mutations in the beta-catenin sequence have been associated with low LOH tumour pro®le and HBV negative status HCCs (Laurent-Puig et al., 2001 ). An over-expression of beta-catenin has been reported to have pathological and prognostic signi®cance (Nhieu et al., 1999; Wong et al., 2001) . Our results therefore suggest a speci®c altered expression of the beta-catenin encoded gene in tumours developing in the absence of cirrhosis.
Finally, our investigation highlighted a distinct pro®les of TGF-beta-superfamily encoding genes in HCC with varying degrees of dierentiation. TGF-beta has been extensively studied as regulator of liver cell proliferation and dierentiation (Fausto, 1991) ; our study may therefore help to dissect these network alterations during dierent stages of liver carcinogenesis.
cDNA microarray is still an emerging technology with several experimental pitfalls (Knight, 2001) . Therefore, before launching large-scale studies, it is important to validate its feasibility in the speci®c experimental context of the tumours under analysis. The number of patients in the present study is small, but the ®ndings support the hypothesis that despite the HCC pattern heterogeneity, the large-scale screening of gene expression may provide data signi®cant to our understanding of the mechanism of liver carcinogenesis. It should also encourage studies on larger patient series, so as to validate the clinical impact of this approach.
Materials and methods
Patients and tissue samples
Tissues from the tumour and from surrounding nontumorous liver were obtained from 15 patients undergoing surgical hepatectomy or liver transplantation for hepatocellular carcinoma (Table 1) . Cancerous and non-cancerous tissues were meticulously dissociated, snap-frozen in liquid nitrogen, and stored at 7808C until use. The tumoral or nontumoral localizations of samples used for RNA puri®cation were veri®ed histologically. Eight patients were HCV positive, six were HBV-positive and one was co-infected with HCV and HBV. Histological analysis of non-tumour tissues showed that 11 HCCs had developed on cirrhotic and four on non-cirrhotic tissues. The tumour was classi®ed histologically, using the Edmondson grading system; ®ve HCCs were de®ned as well dierentiated, and 10 as moderately or poorly dierentiated.
RNA extraction and macroarray hybridizations
Frozen tissues were pulverized in liquid nitrogen using a pestle and mortar. Frozen tissue powder was immediately placed in Trizol Buer (Life Technologies, BRL), and homogenized, and total RNA extraction was performed according to the manufacturer protocol, before storage at 7808C until analysis. Probe synthesis (7 mg of total RNA from tumour and non-tumour tissues) and macroarray hybridization (Cancer 1.2 ± 1 186 genes ± CLONTECH) were performed as indicated by the manufacturer (CLONTECH) using [a-P 32 ]-dATP. Hybridized membranes were exposed to a Phosphor Screen overnight and scanned using a Storm 840 (Molecular Dynamics, Inc, Watertown, MA, USA). For each patient, comparison of the gene expression pro®les of tumour and non-tumour tissue was performed in duplicate during independent experiments (probe synthesis and macroarray hybridization). The radioactive intensity of each spot was analysed with Atlas Image 1.5 software (CLONTECH). Intensity which was twice as high as the background was de®ned as a positive signal. The ratio of tumour versus nontumorous intensity was calculated and normalized using the mean values for the nine housekeeping genes. Genes with a ratio 52 or 05ratio 40.5 were de®ned as up-regulated or down-regulated, respectively.
Semi-quantitative RT ± PCR analysis
To verify macroarray hybridization data, semi-quantitative RT ± PCR was performed. To achieve this, four paired tumour (T) and non-tumour (NT) tissue samples from patients with HCC were used, and the RNA expression level of seven selected genes were evaluated in these paired tissues. Random cDNA synthesis was performed using 15 mg of total RNA, with ®nal concentrations of the following components (Promega): 8 u of M-MLV, 2 mM dNTPs, 16Buer, 0.01 u RNasine. Semi-quantitative PCR was performed on 2 ml (0.4 mg of the starting total RNA) of dierent cDNA dilutions (1, 1/10, 1/100) with 30 cycle numbers. PCR ampli®cations were achieved using the following components (Promega) and conditions: 0.4 mM dNTPs, 0.3 mM primers, 16buer, 0.1 u Taq; denaturation at 948C (5 min); 30 cycles at 948C (1 min), primer hybridization temperature (1 min) and 728C (1 min), then with a 728C extension (10 min). The sequences of the PCR primer pairs of the seven selected genes with the MgCl 2 concentration, the primer hybridization temperature and the expected size of the ampli®ed fragment, were as follows: 40S, 5'-AGC GGA CGC AAC ATG CCA GTG G-3', 5'-TCG CCG ATC AGC TTC AGC TCT T-3' (3 mM, 608C, 103 bp); p-21, 5'-GGA AGA CCA TGT GGA CCT GT-3', 5'-CCC AGC ACT CTT AGG ACC CTC-3' (1.5 mM, 608C, 400 bp), c-myc, 5'-CCA GCA GCG ACT CTG AGG-3', 5'-GTT GTG TGT TCG CCT CTT GA-3' (1.5 mM, 608C, 337 bp), SHP1, 5'-GAC CCC ATG GTC GGG CCA G-3', 5'-CAC CCG AGA GGT GGA GAA AGGC-3' (1.5 mM, 588C, 218 bp), beta-actin, 5'-CAA AGA CCT GTA CGC CAA CAC A-3', 5'-AAC CGA CTG CTG TCA CCT TCAC-3' (2 mM, 608C, 434 bp), Egr1, CLON-TECH primers (2 mM, 568C, 281 bp), ISPK1, CLONTECH primers (2 mM, 538C, 200 bp). Reaction of the 5 ml of RT ± PCR products from each cDNA dilution (1, 1/10, 1/100) were analysed by electrophoresis on 1.5% agarose gel and visualized by ethidium bromide staining. Gel electrophoresis images were saved using Fisher Bioblock Scienti®c software, and the original intensity of each speci®c band was quanti®ed with NIH 1.62 software. The data on paired T and NT tissues from each patients were compared after normalization by the intensity of the 40S ribosomal encoding gene, used as an internal control.
Cluster and statistical analysis
Cluster analysis was performed using Cluster software and visualized using TreeView software (http://rana.Standord.E-DU/Software) (Eisen et al., 1998) . Ratio values were log transferred, ®ltered with a 60% ®lter, and applied to average uncentered linkage clustering. The hierarchical clustering algorithm organizes experimental samples on the basis of overall similarities in their gene expression pro®le patterns. In dendograms, the pattern and length of branches re¯ect the relatedness of samples (patients or genes).
So as to assess the signi®cance of gene expression pro®les related to clinical factors (HBV/HCV, cirrhotic/non-cirrhotic, well/moderately-poorly dierentiated) statistical analyses were performed on genes modulated in at least 30% of the experiments. The relative gene expression pro®les were arranged in two groups and a w 2 -test was performed. In the ®rst group up-regulated genes (ratio 52) were compared with non-up-regulated genes, while in the second group, downregulated genes (05ratio40.5) were compared with nondown-regulated genes. The co-infected patient was excluded from statistical analysis of HBV/HCV comparisons.
